Procedure for including drugs on the essential drugs list: An empirical analysis of decision-making factors

Capa

Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

Goal: To identify the factors influencing decision-making by the Commission of the Ministry of Health of the Russian Federation regarding inclusion of new drugs in the Essential Drugs List. Methodology: A detailed analysis was conducted on the current procedure for forming drug lists established by Government Decree No. 871 of Russia. Regression methods were employed, including linear regression, logit-, and probit-models to determine dependencies between various factors and commission decisions about including a drug into the list. Results: Empirical analysis revealed that existing methodologies for health technology assessment contain shortcomings leading to distortions in decision-making processes. The performed regression analysis demonstrated no clear pattern between proposed characteristics of drugs and voting results of the Commission of the Ministry of Health of the Russian Federation. It is emphasized that further efforts are needed to improve the decision-making system and increase its transparency.

Sobre autores

Ilona Tregub

Financial University under the Government of the Russian Federation

Autor responsável pela correspondência
Email: itregub@fa.ru
ORCID ID: 0000-0001-7329-8344
Código SPIN: 2192-9453
Scopus Author ID: 57189715735
Researcher ID: A-5855-2017

Dr. Sci. (Econ.), Professor

Rússia, Moscow

Anastasia Skripnik

Financial University under the Government of the Russian Federation

Email: nastasja.skripnik@yandex.ru
ORCID ID: 0000-0003-2636-135X
Código SPIN: 8769-0469
Scopus Author ID: OPN-2713-2025
Rússia, Moscow

Bibliografia

  1. Omelyanovsky V.V., Sura M.V., Avksentieva M.V., Khachatryan G.R. Rules for the formation of lists of medicinal products for medical use at the federal level: current status and development prospects. Medical Technologies. Evaluation and Selection. 2018. No. 3 (33). Pp. 9–17. (In Rus.). doi: 10.31556/2219-0678.2018.33.3.009-017. EDN: XYUWIP.
  2. Omelyanovsky V.V., Maksimkina E.A., Ivakhnenko O.I. [et al.] Soimprovement of the system for forming lists of drugs medicinal products for human use: analysis amendments to Decree of the Government of the Russian Federation No. 871. Pharmacoeconomics. Modern Pharmacoeconomics and Pharmacoepidemiology. 2020. V. 13, No. 2. Pp. 113–123. (In Rus.). doi: 10.17749/2070-4909/farmakoekonomika.2020.032. EDN: RBPZBS.
  3. Kuksenok A.R. Analysis of deficiencies in current methods for assessing technical of health care in Russia and proposals for their implementation. Economy and Entrepreneurship. 2021. No. 6 (131). Pp. 1231–1236. (In Rus.). doi: 10.34925/EIP.2021.131.6.240. EDN: OGICBI.
  4. Bezpalova K.S., Mkhitaryan R.M., Dragulenko V.V. Main methods of econometric modeling: overview and comparison. Regional and Sectoral Economy. 2023. No. 5. Pp. 99–103. (In Rus.). doi: 10.47576/2949-1916_2023_5_99. EDN: JUSPNO.
  5. Chernykh M.S. Probit and logit models in econometrics / M.S. Chernykh, E. V. Kleimenova // Modern problems and prospects science, technology and education: Materials II National scientific and practical conference, Magnitogorsk, 10 December 2021 /Edited by I.A. Dolmatova. Magnitogorsk: Magnitogorsk State Technical University. G.I. Nosova, 2022. Pp. 438–441. EDN: IKSCTP.

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML


Creative Commons License
Este artigo é disponível sob a Licença Creative Commons Atribuição–NãoComercial–SemDerivações 4.0 Internacional.

Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).